Amdocs (NASDAQ:DOX) Upgraded to “Buy” at Wall Street Zen

Amdocs (NASDAQ:DOX) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday.

A number of other brokerages also recently weighed in on DOX. Stifel Nicolaus lowered their price target on Amdocs from $88.00 to $71.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Amdocs in a research report on Wednesday, August 5th. Cfra downgraded Amdocs to a “sell” rating in a research note on Thursday, May 14th. Finally, KeyCorp began coverage on Amdocs in a report on Monday, June 29th. They set a “sector weight” rating on the stock. Three equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $86.67.

Amdocs Stock Performance

DOX stock traded up $0.21 during trading hours on Friday, reaching $62.91. The stock had a trading volume of 1,293,158 shares, compared to its average volume of 1,190,782. The stock has a 50-day simple moving average of $55.10 and a 200 day simple moving average of $61.22. Amdocs has a fifty-two week low of $49.74 and a fifty-two week high of $86.14. The stock has a market capitalization of $6.79 billion, a PE ratio of 14.98, a price-to-earnings-growth ratio of 1.09 and a beta of 0.40. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.94 and a quick ratio of 0.94.

Amdocs (NASDAQ:DOX) last released its quarterly earnings data on Thursday, August 6th. The technology company reported $1.84 earnings per share for the quarter, hitting the consensus estimate of $1.84. The company had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.18 billion. Amdocs had a net margin of 9.75% and a return on equity of 20.28%. Amdocs’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.72 EPS. Analysts predict that Amdocs will post 6.57 EPS for the current fiscal year.

Institutional Investors Weigh In On Amdocs

Several hedge funds have recently bought and sold shares of DOX. California State Teachers Retirement System boosted its holdings in shares of Amdocs by 1,194.0% during the second quarter. California State Teachers Retirement System now owns 75,456 shares of the technology company’s stock worth $3,814,000 after acquiring an additional 69,625 shares during the period. TD Waterhouse Canada Inc. increased its stake in shares of Amdocs by 14.1% during the second quarter. TD Waterhouse Canada Inc. now owns 247,521 shares of the technology company’s stock worth $12,682,000 after purchasing an additional 30,555 shares during the period. Rehmann Capital Advisory Group increased its stake in shares of Amdocs by 3.6% during the second quarter. Rehmann Capital Advisory Group now owns 15,351 shares of the technology company’s stock worth $776,000 after purchasing an additional 529 shares during the period. Hennessy Advisors Inc. acquired a new stake in Amdocs during the 2nd quarter worth approximately $92,000. Finally, Greenleaf Trust acquired a new stake in Amdocs during the 2nd quarter worth approximately $201,000. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Key Amdocs News

Here are the key news stories impacting Amdocs this week:

• Positive Sentiment: Zacks Research raised its FY2028 EPS forecast to $7.79 from $7.69 and increased estimates for several quarters, including Q1 2027, Q2 2027, Q2 2028 and Q3 2028. These revisions suggest improved longer-term earnings potential. Amdocs estimates and analyst coverage
• Positive Sentiment: Analysts have set a consensus price target of $86.67, substantially above the stock’s recent trading level, implying considerable potential upside if Amdocs meets or exceeds earnings expectations. Amdocs receives $86.67 consensus target price
• Positive Sentiment: Zacks highlighted Amdocs as a strong momentum stock, which may support investor interest and buying activity. Why Amdocs is a strong momentum stock
• Neutral Sentiment: A potential catalyst is Amdocs’ telecom partnership with Millicom International Cellular (TIGO); stronger growth at Millicom could increase the opportunity for Amdocs’ services, although the article presents this as a possibility rather than a confirmed financial impact. Millicom growth and Amdocs partnership
• Negative Sentiment: Zacks lowered its FY2026 EPS estimate to $6.57 from $6.60 and cut FY2027 EPS to $6.99 from $7.12. It also reduced Q4 2026 and Q3/Q4 2027 forecasts, signaling some pressure on near-term earnings expectations.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.